FMC.NYSEFmc CORP

10-K: FMC Corporation Reports 2024 Results, Outlines 2025 Outlook Amid Market Recovery

Sentiment:

Annual Results


FMC Corporation's 2024 results reflect restructuring benefits and improving demand, while its 2025 outlook anticipates flat revenue growth and increased profitability.

Worse than expectedNet income (loss) attributable to FMC stockholders of $341.1 million decreased $980.4 million from $1,321.5 million in the prior year period.Adjusted after-tax earnings from continuing operations attributable to FMC stockholders of $436.3 million decreased $38.2 million or approximately 8 percent.

Summary

  • FMC Corporation's 2024 revenue reached $4,246.1 million, a 5% decrease compared to the previous year, but volume improved by 3% due to growth in new products.
  • The company's restructuring efforts, known as Project Focus, yielded $165 million in cost benefits in 2024.
  • Gross margin decreased by 10% to $1,648.9 million, with a gross margin percentage of 38.8%.
  • Net income attributable to FMC stockholders decreased significantly to $341.1 million, primarily due to changes in income tax benefits.
  • Adjusted after-tax earnings from continuing operations attributable to FMC stockholders were $436.3 million, down 8%.
  • For 2025, FMC expects revenue between $4.15 billion and $4.35 billion, and adjusted EBITDA between $870 million and $950 million.
  • The company is targeting over $225 million in annual run-rate savings from Project Focus by the end of 2025.
  • FMC is committed to sustainability, targeting net-zero greenhouse gas emissions across its value chain by 2035.

Sentiment

Score: 5

Explanation: The document presents a mixed sentiment. While there are positives such as restructuring benefits and a focus on sustainability, the overall financial results show a decline in revenue and net income. The outlook for 2025 is cautiously optimistic, but there are still uncertainties and challenges ahead.

Positives

  • FMC's restructuring efforts generated $165 million in cost benefits in 2024.
  • Volume improved as the year progressed and resulted in a 3% increase in revenue year over year.
  • The company is targeting over $225 million in annual run-rate savings from Project Focus by the end of 2025.
  • FMC is committed to sustainability, targeting net-zero greenhouse gas emissions across its value chain by 2035.

Negatives

  • FMC Corporation's 2024 revenue was $4,246.1 million, a 5% decrease year-over-year.
  • Gross margin decreased by 10% to $1,648.9 million, with a gross margin percentage of 38.8%.
  • Net income attributable to FMC stockholders decreased significantly to $341.1 million.
  • Adjusted after-tax earnings were $436.3 million, down 8%.

Risks

  • The company faces risks related to climate conditions, changing regulatory environments, and geographic presence outside the U.S.
  • Fluctuations in commodity prices and supply arrangements could adversely affect operating results.
  • Business disruptions, litigation, and environmental risks could impact the company's financial condition.
  • The company's future performance will depend on its ability to address expiration of active ingredient composition of matter patents.
  • Information technology security and data privacy risks could disrupt business operations and result in loss of assets.

Future Outlook

FMC expects 2025 revenue to be in the range of approximately $4.15 billion to $4.35 billion, and adjusted EBITDA of $870 million to $950 million.

Management Comments

  • FMC is guided by our strategic plan which aims to transform our relationship with growers to become a trusted source for technical expertise and innovative solutions, to deliver superior growth and returns to our stakeholders, and to lead the crop protection industry in safety, talent, sustainability, and innovation.

Industry Context

The agrochemicals industry is more consolidated following several mergers of the leading crop protection companies, which now include FMC, ChemChina (owner of Syngenta Group, which includes the former Syngenta and Adama), Bayer AG (acquired Monsanto in 2018), BASF AG and Corteva Agriscience.

Comparison to Industry Standards

  • The five innovation companies currently represent approximately 72 percent of the crop protection industrys global sales.
  • The next group of agrochemical producers include UPL Ltd., Sumitomo Chemical Company Ltd., and Nufarm Ltd.
  • FMC employs various differentiated strategies and competes with unique technologies focusing on certain crops, markets and geographies, while also being supported by a low-cost manufacturing model.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chief Executive OfficerMark DouglasPierre R. BrondeauN/AN/A
PresidentN/ARonaldo Pereira2024N/A
Executive Vice President and Chief Marketing OfficerN/ABrian P. Angeli2024N/A
Executive Vice President, Integrated Supply ChainN/AThaisa Hugenneyer2024N/A
Executive Vice President, Chief Technology OfficerN/AVsevolod Rostovtsev2024N/A

Legal Proceedings

  • As of December 31, 2024, there were approximately 11,683 premises and product asbestos claims pending against FMC in several jurisdictions.
  • In June 2024, FMC initiated a lawsuit against Sharda USA LLC in the U.S. District Court for the Eastern District of Pennsylvania (Philadelphia) for infringing two US Patents directed to insecticidal compositions containing the combination of bifenthrin and zeta-cypermethrin.
  • In August 2024, FMC successfully obtained a preliminary injunction in the form of a Temporary Restraining Order (TRO).
  • FMC filed a patent infringement case against Albaugh in the US District Court (Iowa), based on public information disclosed in Albaughs EPA dossier.
  • In November 2024, FMC and Albaugh reached an agreement to resolve the case.
  • In December 2024, Atticus LLC filed a declaratory judgment case against FMC in the US District Court for the Western District of North Carolina.

Stakeholder Impact

  • FMC is committed to delivering products that improve agricultural productivity while protecting the environment for future generations.
  • The company strives to create an environment that fosters a culture of belonging across its team of 5,700 global employees.
  • FMC is aligned with the UN Sustainable Development Goals #2 (Zero Hunger), #8 (Decent Work and Economic Growth), #13 (Climate Action) and #15 (Life on Land).

Next Steps

  • FMC will continue to implement its Project Focus restructuring plan.
  • The company will focus on accelerating development and commercialization of its pipeline.
  • FMC will continue to defend its intellectual property rights.
  • The company will work with its entire value chain to reduce GHG emissions and mitigate potential impacts on climate change.

Key Dates

DateDescription
1928FMC Corporation was incorporated in Delaware.
2018Bayer AG acquired Monsanto.
March 2019FMC Lithium spin-off completed.
Late 2020Elevest, Vantacor, and Altacor eVo launched in the US and other countries.
Late 2022Composition of matter patents covering Rynaxypyr active started expiring in certain countries.
March 2023FMC received validation on its near-term and net-zero targets in line with the Paris Agreement.
November 2023Project Focus, a global restructuring plan, was initiated.
November 1, 2024Sale of the non-core Global Specialty Solutions (GSS) business to Envu was completed.
December 31, 2024124,840,902 of the registrant's common shares outstanding.
February 2025FMC filed a motion to dismiss Atticus' complaint for failure to state a case or controversy.
February 2025FMC entered into new amendments to its Revolving Credit Facility.
April 29, 2025FMC's annual meeting of stockholders will be held.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.